Clinical trial · Observational
Symptom Clusters in Hong Kong Chinese Children With Blood Cancer
Symptom Clusters in Hong Kong Chinese Children With Blood Cancer:: A Longitudinal Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Pediatric blood cancer is the most common childhood malignancy. Despite its survival has been substantially improved, children still have to pay a high price for numerous distressing symptoms resulted from chemotherapy. Previous studies related to symptom experiences mainly focus on individual symptoms, rather than on multiple symptoms. Understanding these distressing symptoms may help healthcare professionals to develop appropriate and effective interventions with the aims of alleviating symptom severity and thus promoting the child's psychosocial well-being and quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Child | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Questionnaire
- description
- This study aims to examine the cancer patient's symptom clusters and their changes over chemotherapy among pediatric patients with blood cancer in Hong Kong
- interventionNames
- Other: Questionnaire
Primary outcomes (6)
- measure
- The therapy-related symptom checklist for children (TRSC-C)
- timeFrame
- Before chemotherapy
- description
- For measuring the occurrence and severity of symptoms experienced by patients aged 5-17 when they undergo cancer treatment.
- measure
- The therapy-related symptom checklist for children (TRSC-C) at 1-week
- timeFrame
- At 1-week follow-up
- description
- For measuring the occurrence and severity of symptoms experienced by patients aged 5-17 when they undergo cancer treatment.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 5 Years
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: * aged 5 - 17 years old * diagnosed with blood cancer but not yet receive any chemotherapy * able to communicate with Cantonese and read Chinese Exclusion Criteria: * who are scheduled to have concurrent cancer treatment * with recurrent malignancy * medical condition, or cognitive and learning problems in their medical records
References
Publications (0)
Data not yet available